Why “Better Forecasting” in Clinical Supply Might Not Be the Answer

Written by: Andy Russell, Vice President, Growth & Product Strategy at RxE2The San Diego Signal: An Industry Carrying a Heavy Load There was a moment coming out of GCSG this year where something started to feel different. Not because we suddenly discovered new problems. We didn’t. If anything, the industry showed just how well it…

The Industry Documented the Symptoms. It’s Time to Treat the Root Cause

The recent 2026 U.S. Annual Conference of the Global Clinical Supplies Group in San Diego felt different than previous years. In the past, these gatherings often focused on the promise of distant technologies or abstract innovations. However, the tone this year was grounded in a heavy sense of pragmatism. Leaders from the largest pharmaceutical organizations…

Unlocking Community-Based Trials: Major Takeaways from the Inaugural RxE2 Un-Conference

We are delighted to share the insights and collaborative energy from the first of its kind un-conference for Pharmacists in clinical research, hosted by RxE2. Held on October 24th, 1 pm ET, this landmark event occurred during American Pharmacists Month, emphasizing the profession’s pivotal role in advancing healthcare. For those who missed the dynamic conversations,…